Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 6 of 6 Projects
Project # Contact PI Funding Organization Fiscal Year
ETHERAL : Epigenetic THERapy in ALzheimer’s Disease . A multicenter, multinational, randomized, double-blind, placebo-controlled, 3-arm, 26 weeks parallel-group study to evaluate the safety, tolerability of ORY-2001 in patients with mild-moderate AD
GC-201801-2014666 Bullock, Roger Alzheimer's Drug Discovery Foundation 2018
Clinical development of a companion marker for treatment with the dual LSD1/MAO-B inhibitor ORY-2001
GC-2012832 Maes, Tamara Alzheimer's Drug Discovery Foundation 2016
Preclinical development of ORY-2001, a dual LSD1/MAOB inhibitor for the treatment of Alzheimer disease.
GC-2012231 Maes, Tamara Alzheimer's Drug Discovery Foundation 2015
First In Class Modifying Disease Drugs for Alzheimer's Disease
20100902 VEN-Maes-2010 Maes, Tamara Alzheimer's Drug Discovery Foundation 2010
High-throughput-screening for compounds against Aph1B-gamma-secretase
290701-De Strooper-2009 De Strooper, Bart Alzheimer's Drug Discovery Foundation 2009
Drug Discovery for Progranulin-Mediated Frontotemporal Lobar Degeneration
291208 AFTD-Van Damme-2009 Van Damme, Philip Alzheimer's Drug Discovery Foundation 2009